Analyst consensus rating
Abbott Laboratories Analyst Rating: Buy
ABT is rated Buy by 25 analysts with a $120.20 target. As of 2026-08-26.
Direct answer
Abbott Laboratories's consensus rating is Buy.
25 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $120.20.
Forecast evidence checked August 26, 2026.
Get free Abbott Laboratories email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $114.70
- Average price target
- $120.20
- High price target
- $135.00
- Low price target
- $103.00
- Low target gap
- -10.2%
- Target upside
- +4.8%
- High target gap
- +17.7%
- Target range width
- 27.9%
- Consensus rating
- Buy
- Analysts
- 25
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Abbott Laboratories?
Abbott Laboratories has a verified Buy consensus. The same dataset has an average price target of $120.20.
How far are Abbott Laboratories's low and high targets from the recorded price?
The low target implies -10.2%, while the high target implies +17.7%.
How many analysts are included in Abbott Laboratories's consensus?
The verified consensus includes 25 analysts.
How is Abbott Laboratories's target upside or downside calculated?
The average target of $120.20 is divided by the recorded price of $114.70, then one is subtracted to produce +4.8%. This does not guarantee a future return.
When was Abbott Laboratories's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.